| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1999;34:207-211.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Laboratoire de Pharmacologie Cardiovasculaire, Faculté de Pharmacie, Henri Poincaré UniversityNancy 1, Nancy (P.G., I.L.-I., V.M., N.N., J.-M.C., J.A.), and Laboratoire de Pharmacologie, Université Paris XI, Châtenay-Malabry (C.C.-A.), France. The present address of Nathalie Niederhoffer is Department of Pharmacology, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Correspondence to Jeffrey Atkinson, Laboratoire de Pharmacologie Cardiovasculaire, Faculté de Pharmacie, UHP-Nancy 1, BP 403, 54001 Nancy, France. E-mail atkinson{at}pharma.u-nancy.fr
| Abstract |
|---|
|
|
|---|
Key Words: medial stress aorta hypertension rat treatment age
| Introduction |
|---|
|
|
|---|
The structural increase in lumen diameter may be provoked by factors other than pressure, such as fracture of the elastin-retaining network under the long-term cumulative fatiguing effects of cyclic stress on the arterial wall.7 Thus, blood pressure alone may not be the major determinant in the severity of the effects of hypertension. Reversal of such changes may require a much longer period of treatment than those used in previous studies. If antihypertensive treatment does not lower internal diameter, then the wall thickness/internal diameter ratio may be too low for a given intraluminal pressure, and thus wall stress would remain elevated despite treatment.
The effect of short-term antihypertensive treatment on medial hypertrophy in young animals has been extensively studied, but the effect of long-term treatment on internal diameter in old hypertensive animals has received scarce attention. This should provide a better paradigm for the human situation, because hypertension is essentially a disease of the aged.
This study examined the effect of antihypertensive treatment with a combination of the angiotensin Iconverting enzyme inhibitor captopril and the diuretic hydrochlorothiazide (CAP) on blood pressure, thoracic aorta lumen diameter, medial cross-sectional area, and stress in mature (9 months) and old (15 months) spontaneously hypertensive rats (SHRs). The rationale for combined treatment with an angiotensin Iconverting enzyme inhibitor and a thiazide diuretic is based on clinical observations showing that such a combination lowers blood pressure efficiently8 and may have a beneficial effect on aortic remodeling.9
| Methods |
|---|
|
|
|---|
Animals and Long-term Drug Treatment
Three-month-old male SHRs (SHR/CON rats; body weight, 317±9 g;
Iffa-Credo, L'Arbresle, France) and Wistar-Kyoto (WKY) rats (body
weight, 308±2 g; Iffa-Credo) were given standard rat chow and water ad
libitum. A third group of rats (SHR/CAP rats; body weight, 301±5 g;
Iffa-Credo) were given chow mixed with captopril (59 to 39 mg ·
kg-1 · d-1) and
hydrochlorothiazide (30 to 19 mg ·
kg-1 · d-1) for 6
or 12 months. There were no deaths. In our laboratory, there is
substantial mortality in untreated SHRs beyond 15 months such that
there are no survivors at 18 months (unpublished results).
Systolic arterial blood pressure was recorded by the tail-cuff method10 before and 6 and 12 months after the onset of treatment. Experiments were performed in conformity with the recommendations of the European Union and Nancy University on animal welfare.
Aortic Structure
Rats were infused for 30 minutes under pressure with 10% formol
containing PBS (mmol/L: NaCl, 120; KCl, 2.7; and PBS, 10; pH 7.4 at
25°C) via a cannula implanted in the right common carotid artery
under ether anesthesia. Pressure was fixed at a level
corresponding to the central aortic mean pressure calculated from tail
artery systolic pressure.4 The thoracic aorta was
excised and immersed in 10% formol. A 1-cm specimen was dehydrated in
graded ethanol solutions and embedded in paraffin. Three 20-µm-thick
sections were cut and stained with Weigert's reagent (for elastin) for
determination of lumen diameter and medial thickness.
Morphometric analysis was performed with the Optilab algorithm. Each section was examined 3 times in a blinded manner. Medial cross-sectional area (mm2) was defined as the area between the internal and external elastic lamina. Medial stress was calculated as follows: (systolic arterial blood pressurexlumen radius)/medial thickness (dynes · cm-2 · 106).
The outward hypertrophic remodeling ratio was defined as the slope of the linear positive relationship between medial cross-sectional area (mm2) and lumen diameter (mm).
Left Ventricular Mass
The heart was removed, and the left ventricle (plus septum) was
dissected free and weighed. Because body weights were significantly
different in some cases, left ventricular mass was
expressed as left ventricular weight (g) divided by body
weight (kg).
Statistical Analysis
Results are mean±SE. ANOVA followed by the Bonferroni test was
used for the comparison of means; P<0.05 was considered
statistically significant. Interactions between different variables
were also evaluated by multiple regression analysis.
| Results |
|---|
|
|
|---|
3%;
P>0.05) differences in body weight between WKY rats and
SHRs. CAP stunted growth (-11% at 9 months; -13% at 15 months;
both, P<0.05 versus SHR/CON rats).
|
Systolic arterial blood pressure was higher in SHRs at 3 months (+33%; P<0.05 versus WKY rats). During maturation, there was a slight increase in blood pressure in SHRs (+13%; P<0.05); with aging, there was a minor, nonsignificant fall (-2%; P>0.05). Blood pressure varied little in WKY rats (-3% at 3 to 9 months; +5% at 9 to 15 months; both, P>0.05). CAP normalized blood pressure (-31% at 9 months; -25% at 15 months; both, P<0.05 versus SHR/CON rats).
At 3 months of age, left ventricular mass was similar in SHRs and WKY rats (P>0.05). Left ventricular mass increased substantially with maturation (WKY rats, +25%; SHRs, +39%; both, P<0.05) but less with aging (WKY rats, +13%; SHRs, +20%; both, P<0.05). CAP stopped the increase in left ventricular mass, which was lower than in SHR/CON rats (-16% at 9 months; -32% at 15 months; both, P<0.05) or WKY rats (-14% at 9 months; -16% at 15 months; both, P<0.05). Drug consumption in the SHR/CAP group fell steadily throughout the study.
Thoracic Aorta Lumen Diameter, Medial Cross-Sectional Area,
and Stress
At 3 months of age, lumen diameter (+10%), medial
cross-sectional area (+19%), and calculated wall stress (+34%) were
higher in SHRs than in WKY rats (P<0.05; see Figure 1).
|
The thoracic aorta dilated with maturation in all groups (WKY rats, +17%; SHR/CON rats, +28%; SHR/CAP rats, +26%; all, P<0.05). CAP slightly reduced diameter in old SHRs (-9% versus SHR/CON rats, P<0.05).
Medial cross-sectional area increased with maturation in all 3 groups (WKY, +41%; SHR/CON, +78%; SHR/CAP, +27%; all, P<0.05). With aging, there was an additional slight but significant increase in WKY rats (+13%, P<0.05) but not in SHR/CON rats (+11%, P>0.05) or SHR/CAP rats (-5%, P>0.05). CAP normalized medial cross-sectional area (-26% at 9 months; -37% at 15 months; both, P<0.05 versus SHR/CON rats).
Medial stress in SHRs was higher than in WKY rats by an average of 0.60 dynes · cm-2 · 106 in SHR/CON rats and 0.50 dynes · cm-2 · 106 in SHR/CAP rats (both, P<0.05). Maturation had no effect on medial stress, but aging produced a slight significant decrease (average, -0.24±0.20 dynes · cm-2 · 106; P<0.05). CAP had no effect on medial stress.
Remodeling and Medial Stress
All groups showed outward hypertrophic remodeling because medial
cross-sectional area increased in parallel with the increase in lumen
diameter. This occurred in a similar way in WKY and SHR/CON rats; in
SHRs, CAP lowered the slope relating medial cross-sectional area to
lumen diameter at 15 months (Table 2).
|
In all groups, calculated wall stress decreased as outward hypertrophic remodeling ratio increased. This occurred in a similar way in WKY and SHR/CON rats; in SHRs, CAP increased the slope relating medial stress to remodeling ratio at 15 months (Table 3).
|
| Discussion |
|---|
|
|
|---|
In this article, remodeling is defined on the basis of changes in the ratio of medial cross-sectional area to lumen diameter. With structural dilation of the thoracic aorta, there was an increase in medial cross-sectional area. This implies that there was not simply a rearrangement of existing medial cells and extracellular matrix around a larger diameter but that as diameter increased, more cells and matrix were formed. Thus, to use the term suggested by Mulvany et al,11 outward hypertrophic remodeling occurred.
Effect of Aging and Hypertension on Cardiovascular
Remodeling
Aging in the absence of any marked increase in intraluminal
pressure may induce an increase in internal diameter through the
long-term cumulative fatiguing effects of cyclic stress on the
arterial wall.7 In this study, such a
phenomenon may have been occurring in normotensive WKY rats, in which
internal diameter increased significantly with age (3 to 15 months,
+16%; P<0.05) but blood pressure did not (+8%;
P>0.05). Medial hypertrophy may then follow to
keep wall stress constant. Multivariate regression
analysis with the use of medial cross-sectional area as the
dependent variable and blood pressure and lumen diameter as the
independent variables revealed a significant effect of diameter
(P<0.0001) but not pressure (P=0.1386). The
increase in diameter cannot be the only factor involved, however,
because medial cross-sectional area increased to values beyond those
necessary to compensate for dilatation (slopes in Table 2 are
positive and greater than unity). Thus, the ratio of medial
cross-sectional area to internal diameter increased by 38% from 3 to
15 months (0.22±0.03 to 0.30±0.03 mm; P<0.05). This
suggests that age has a supplementary effect on medial
hypertrophy beyond that to be expected by age-linked
dilatation.
Pressure seems to be less important than aging in relation to another aspect of cardiovascular remodeling in WKY rats, the increase in left ventricular mass. There was a 40% (P<0.05) increase in left ventricular mass from 3 to 15 months, once again in the absence of any significant increase in blood pressure (see above). Blood pressure was not a significant determinant (P=0.1832) of left ventricular mass in multivariate analysis (independent variables were pressure and age).
Hypertension in the absence of aging can be studied in young (3-month-old) SHRs. In young SHRs, blood pressure was substantially increased (+33% versus age-matched WKY rats; P<0.05), yet internal diameter was only moderately increased (+10%; P<0.05), and the ratio of medial cross-sectional area to internal diameter was not significantly higher (+6%; P>0.05). This suggests that pressure is not an important determinant of large-artery remodeling or that the effects of pressure take time to develop. Thus, there may be a significant interaction between hypertension and aging. In our data, there is evidence for and against this. In multivariate analysis, blood pressure is a significant determinant of lumen diameter at 9 months (P=0.0520) but not at 3 (P=0.281) or 15 months (P=0.9141). Blood pressure did increase significantly from 3 to 15 months. The increase was small (+11%), whereas a substantial increase occurred in the medial cross-sectional area/internal diameter ratio (+60% from 0.23±0.03 to 0.37±0.03 mm; P<0.05). Aging appears to have a proportionally greater effect than blood pressure.
In SHRs, remodeling did not compensate for increased pressure because wall stress was higher than in WKY rats at all ages. This suggests that active force could be important in the "protection" of the aorta against high blood pressure. Another possibility is that wall composition changes. Results on the change in the elastin/collagen ratio with hypertension are conflicting, with some studies showing an increase13 and others a decrease.2 Studies in old hypertensive models are lacking. Changes in other wall components or in cell-matrix attachments may also be important.
CAP treatment reduced medial cross-sectional area. This is not an original observation. It is interesting to note, however, that thoracic aorta remodeling (Table 2) and the relationship between wall stress and remodeling (Table 3) were different in 15-month-old SHR/CAP rats after 1 year of CAP treatment and SHR/CON rats. The medial cross-sectional area/internal diameter ratio was lower in SHR/CAP rats (0.26±0.03 mm) than in SHR/CON rats (0.37±0.03 mm, P<0.05). Thus, CAP lowered medial cross-sectional area but not wall stress. This suggests that some change in active force, wall composition, or cell-matrix attachments occurred because this combination of drugs appears to lower arterial stiffness.9 Here again, previous results are similar, with some showing that antihypertensive treatment reduces wall collagen content3 and others showing no effect.2 5 Some authors14 describe a "protective" effect of angiotensin Iconverting enzyme inhibitors on elastin, whereas others2 do not find this effect.
Animal Model of Human Aortic Remodeling
In WKY rats and SHRs, the main changes in aortic inner diameter
and medial cross-sectional area occurred during maturation, with less
change occurring with aging. This is not the case in humans, in whom
aortic diameter increases linearly with age up to the eighth
decade.15 The increase in diameter is associated with
extensive calcification,15 which, although it occurs in
WKY rats and SHRs, is generally far less marked in animal models than
in humans.16 Thus, in humans, the process of
elastocalcinosis (accumulation of calcium on medial elastin fibers
followed by breakdown of the elastin fiberretaining network) may be
more important than in the WKY or SHR model, and degradation of the
aortic media may play a more important role in structural dilatation
with age.
| Acknowledgments |
|---|
Received September 23, 1998; first decision October 26, 1998; accepted April 19, 1999.
| References |
|---|
|
|
|---|
2.
Levy BI, Michel JB, Salzmann JL, Azizi M,
Poitevin P, Safar M, Camilleri JP. Effects of chronic inhibition of
converting enzyme on mechanical and structural properties of arteries
in rat renovascular hypertension. Circ Res. 1988;63:227239.
3.
Levy BI, Duriez M, Phillipe M, Poitevin P, Michel JB.
Effect of chronic dihydropyridine (isradipine) on
the large arterial walls of spontaneously hypertensive
rats. Circulation. 1994;90:30243033.
4.
Amin F, Niederhoffer N, Tatchum-Talom R, Makki T,
Guillou J, Tankosic P, Atkinson J. A new technique for the study of
impact of arterial elasticity on left
ventricular mass in rats. Am J Physiol. 1996;270:H981H987.
5.
Michel JB, Heudes D, Michel O, Poitevin P, Philippe M,
Scalbert E, Corman B, Levy BI. Effect of chronic ANG I-converting
enzyme inhibition on aging processes, II: Large arteries. Am
J Physiol. 1994;267:R124R135.
6. Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure. J Cardiovasc Pharmacol. 1994;23:S30S37.
7. Glagov S. Hemodynamic risk factors: mechanical stress, mural architecture, medial nutrition and the vulnerability of arteries to atherosclerosis. In: Wissler RN, Geer JC, eds. Pathogenesis of Atherosclerosis. Baltimore, Md: Williams and Wilkins; 1972:164199.
8. Clarke PFF, Kendall R, Hornby R, Kendall MJ. Captopril and hydrochlorothiazide: a safe antihypertensive for use in general practice? J Clin Pharm Ther. 1991;16:361366.[Medline] [Order article via Infotrieve]
9. Bénétos A, Laflèche A, Asmar R, Gautier S, Safar S, Safar ME. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. J Hum Hypertens. 1996;10:7782.[Medline] [Order article via Infotrieve]
10. Chillon JM, Capdeville-Atkinson C, Lartaud I, Guillou J, Mertès PM, Atkinson J. Chronic antihypertensive treatment with captopril plus hydrochlorothiazide improves aortic distensibility in the spontaneously hypertensive rat. Br J Pharmacol. 1992;107:710714.[Medline] [Order article via Infotrieve]
11. Mulvany MJ, Baumbach EL, Aalkjaer C, Heargerty AM. Vascular remodeling. Hypertension. 1996;28:505506.
12.
Wolinsky MD, Glagov S. Structural basis for the static
mechanical properties of the aortic media. Circ Res. 1964;14:400413.
13. Berry CL, Greenwald SE. Effects of hypertension on the static mechanical properties and chemical composition of the rat aorta. Cardiovasc Res.. 1976;10:437451.[Medline] [Order article via Infotrieve]
14. Makki T, Tatchum-Talom R, Niederhoffer N, Amin F, Tankosic P, Mertès PM, Atkinson J. Increased distensibility induced by the angiotensin-converting enzyme inhibitor, lisinopril, in normotensive rats. Br J Pharmacol. 1994;111:555560.[Medline] [Order article via Infotrieve]
15. Dixon AK, Lawrence JP, Mitchell JRA. Age-related changes in the abdominal aorta shown by computed tomography. Clin Radiol. 1984;35:3337.[Medline] [Order article via Infotrieve]
16. Fleckenstein A, Fleckenstein-Grün G, Frey M, Zorn J. Calcium antagonism and ACE inhibition: two outstandingly effective means of interference with cardiovascular calcium overload, high blood pressure and arteriosclerosis in spontaneously hypertensive rats. Am J Hypertens. 1989;2:194204.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. M. Seubert, F. Xu, J. P. Graves, J. B. Collins, S. O. Sieber, R. S. Paules, D. L. Kroetz, and D. C. Zeldin Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F552 - F561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Reckelhoff and L. A. Fortepiani Novel Mechanisms Responsible for Postmenopausal Hypertension Hypertension, May 1, 2004; 43(5): 918 - 923. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |